Low plasma vitamin D levels in patients with familial Mediterranean fever
Tóm tắt
Familial Mediterranean fever (FMF) is an autosomal recessive, inherited autoinflammatory disease characterized by recurrent, self-limited attacks of fever and inflammation of serosal surfaces. There is an explosion of the data regarding inflammatory markers in FMF and clinical effects of chronic inflammation on the disease presentation. Vitamin D (vit D) is the common denomination of a group of sterols with a crucial role in phospho-calcium metabolism. There are some data about the importance of vit D in the initiation and propogation of a range of autoimmune diseases. The aim of the present study was to determine whether vit D deficiency is present in patients with FMF compared with healthy individuals. The study group included 99 patients with diagnosis of FMF attended to our outpatient Rheumatology and Nephrology Clinics of Atatürk Education and Research Hospital. The control group comprised 51 age- and sex-matched healthy people selected from hospital staff. Serum baseline 25-hydroxy vit D levels were measured by HPLC method using an Agilent 1100 Liquid Chromatograph. We found significantly lower serum 25-hydroxy vit D levels among FMF patients compared with matched controls and a high prevalence of vit D deficiency. This study demonstrated that vit D deficiency is frequent in patients with FMF than the healthy controls. It is convenient to look for vit D deficiency and to correct vit D nutritional status in FMF patients.
Tài liệu tham khảo
Ben-Zvi I, Livneh A (2010) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol [Epub ahead of print]
Jarjour RA, Dodaki R (2011) Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep 38(3):2033–2036
Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31
Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923
Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885
Leventis P, Patel S (2008) Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology (Oxford) 47(11):1617–1621
Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17(1):6–10
Cutolo M (2008) Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 10(6):123
Yuksel S, Samli H, Colbay M et al (2009) Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. Tohoku J Exp Med 217(4):321–327
Suyani E, Ozturk MA, Deger SM, Demirag MD, Goker B, Haznedaroglu S (2008) Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study. Clin Rheumatol 27(9):1171–1175
Yıldırım K, Karatay S, Cetinkaya R et al (2010) Bone mineral density in patients with familial Mediterranean fever. Rheumatol Int 30(3):305–308
Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KI (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004
Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16
Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):532–537